Who tends to be eligible, which routes exist, and why NHS access is real but limited.
In the UK, GLP-1 medicines are prescription-only — there's always meant to be a qualified prescriber standing between you and the medicine. On the NHS, access follows defined rules rather than simply being a matter of asking, and understanding those rules makes the whole process feel far less mysterious.
It helps to start with a reassuring fact: NHS access to these medicines is real. People do receive GLP-1 treatment through the health service every day. It's just channelled towards those expected to benefit most, through specific routes, and that's why it can feel harder to obtain than the headlines might suggest.
Broadly, there are two doorways. For type 2 diabetes, GLP-1 medicines are prescribed within established diabetes care — your GP or diabetes team may consider one as part of your wider treatment when you meet the relevant criteria. For weight management, access is typically arranged through specialist weight-management services and within the recommendations NICE has set.
Knowing which doorway applies to you is the single most useful thing to sort out early. The conversation, the criteria and the service involved are quite different depending on whether the goal is managing diabetes or managing weight.
The NHS focuses these medicines on the people who stand to benefit most, and provision can vary from one area to another and with the capacity of local services. Some products have also been introduced to particular groups in stages rather than all at once, so what's offered in your area may differ from a friend's experience elsewhere.
None of this is a judgement on you. It reflects a service trying to direct a limited, in-demand treatment to where the evidence says it will do the most good — and that picture genuinely does shift as guidance is updated.
A little preparation makes appointments smoother and less stressful. You don't need to argue a case — you're simply helping your clinician work out whether a GLP-1 fits your situation.
Being told you don't currently qualify can feel deflating, but it's rarely the end of the story. Eligibility hinges on criteria that can change, and your own circumstances can change too. It's a fair thing to revisit at a future review rather than something to take as a permanent no.
Access changes Eligibility and availability shift as guidance updates and services expand. If you don't qualify today, it's perfectly reasonable to ask again later.
Curious how the rules are actually set? See Who Decides? The MHRA and NICE, Explained Simply. Considering the private route instead? See Getting a GLP-1 Privately in the UK.